Avalo is a plant biotech company using AI and evolution to make a more sustainable and resilient food system.
Avalo has raised $11.0M in total funding. The most recent round was Series A. The last funding was announced in March 2025.
Avalo's investors include Giant Ventures, SOSV, Better Ventures, Germin8 Ventures, At One Ventures.
Avalo is headquartered in Durham, United States.
Avalo is a plant biotech company using AI and evolution to make a more sustainable and resilient food system.
Avalo is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Avalo — Funding & Investors." VCBacked, March 6, 2025, https://www.vcbacked.co/company/avalo. Accessed October 30, 2026.
VCBacked. (2025). Avalo — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/avalo
{{cite web |title=Avalo — Funding & Investors |url=https://www.vcbacked.co/company/avalo |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated